Aug 13 (Reuters)-
Noile-Immune Biotech Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2026 Jun 30, 2025 Dec 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 4 mln
(+65.7 pct)
Operating loss 419 mln loss 412 mln
Recurring loss 370 mln loss 410 mln
Net loss 372 mln loss 411 mln
EPS loss 8.59 yen loss 9.51 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Noile-Immune Biotech Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4893.T